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Abstract
The 2010 International Conference on Bioinformatics, InCoB2010, which is the annual conference of the Asia-Pacific
Bioinformatics Network (APBioNet) has agreed to publish conference papers in compliance with the proposed
Minimum Information about a Bioinformatics investigation (MIABi), proposed in June 2009. Authors of the confer-
ence supplements in BMC Bioinformatics, BMC Genomics and Immunome Research have consented to cooperate
in this process, which will include the procedures described herein, where appropriate, to ensure data and soft-
ware persistence and perpetuity, database and resource re-instantiability and reproducibility of results, author and
contributor identity disambiguation and MIABi-compliance. Wherever possible, datasets and databases will be sub-
mitted to depositories with standardized terminologies. As standards are evolving, this process is intended as a
prelude to the 100 BioDatabases (BioDB100) initiative whereby APBioNet collaborators will contribute exemplar
databases to demonstrate the feasibility of standards-compliance and participate in refining the process for peer-
review of such publications and validation of scientific claims and standards compliance. This testbed represents
another step in advancing standards-based processes in the bioinformatics community which is essential to the
growing interoperability of biological data, information, knowledge and computational resources.
Background
Over the past decade the volume of bioinformatics pub-
lications has grown tremendously. Within the scientific
community, there have been concerns about disappear-
ing databases, lack of interoperability, incomplete disclo-
sure, and general quality and integrity issues. Efforts
have been made to promote uniqueness and universality
in standardized identifiers including Life Science Identi-
fiers (LSID) [1], Digital Object Identifiers (DOI) [2] and
CrossRef [3], author and contributor identifiers [4] (e.g.
ResearcherID [5], Scopus Author Identifier [6], Open
Researcher & Contributor ID [7]); in checklists of mini-
mum information reporting (such as the MIBBI project
[8]); and in the use of standard nomenclature, controlled
vocabularies and ontologies [9]. The ultimate goal would
be for the community to achieve a systematically orga-
nized, universally adopted and disciplined approach in
building and organizing the corpus of biological knowl-
edge that is accurate, reliable, trustworthy, consistent
and persistent. The entire information infrastructure
endorsed and used by the community should be univer-
sally accessible, wholly interoperable, secure, robust, sus-
tainable in perpetuity, backward compatible and where
possible, future proofed.
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any medium, provided the original work is properly cited.Just like the Internet, where open standards backed by
implementable code and use-case exemplars are univer-
sally adopted, all actors and stakeholders in the process
of scientific discovery and publication must be involved
if we are to achieve bioinformatics standards of compar-
able universality. In our effort to advance standards for
bioinformatics activities, we have assembled a set of
publishers, editors, reviewers, authors, contributors,
database and resource administrators, programmers and
scientists who are involved in our annual International
Conference on Bioinformatics and the publication of
our conference supplements, as an exemplar of how
such a process for standardization can take place.
Through this multi-stakeholder effort, we hope that the
lessons learnt will be able to shed light on how we can
plan and coordinate a systematic approach and evaluate
them for possible extension to a wider community. The
aspects tested in this process are limited to the follow-
ing, which we believe is sufficiently wide enough for
facilitating a larger effort to build 100 biological and
bioinformatics databases (BioDB100) which are stan-
dards-compliant:
a. Data and software persistence and the basis for per-
petuity [10]
b. Re-instantiability and reproducibility [11]
c. Author and Contributor Identity Disambiguation
[12]
d. Minimum Information about a Bioinformatics
investigation (MIABi) as described in this report and as
harmonized with initiatives in MIBBI [8] and those of
the International Society for Biocuration (ISB) [13], spe-
cifically BioDBcore [14].
With this platform of standards-compliant databases,
we hope that it will lay the groundwork for studying
how we can implement increasingly standardized termi-
nology, controlled vocabulary, standardized ontologies
and infrastructural and informational interoperability,
such as use of international computational grids [15]
and cloud computing as backend computing resources
for the maintenance and sustainability of knowledge
resources of ever-increasing sophistication.
Data and software repository
Software, datasets and databases described in the Inter-
national Conference on Bioinformatics, InCoB2010 pub-
lished in this conference supplement issue are required
to be deposited in distributed repositories which have
sufficient collective guarantee of perpetuity. As much as
all open source publicly available papers can be accessed
long after the publication date, the corresponding data,
datasets and software described should be just as easily
accessible for future researchers to reproduce, verify and
validate the claims and findings or otherwise, and hope-
fully to improve on them and advance the field. A
deposition of material corresponding to each publication
with version control, unique identifiers, adequate
descriptors and metadata, should be managed and prop-
erly curated, as part and parcel of the publication pro-
cess. Currently many journals have a section called
“supplementary material” where additional information
can be tagged along with the main publication. This
material, however, is generally unstructured or little
effort is made to establish metadata to describe the
content.
We propose that when databases are described in a
publication, a copy should be frozen, version-labelled
and dated for reference. Any subsequent updates with
fully described new features or errata can also be added
for supplementation of the initial deposited material.
Should the corresponding live database referenced in
the publication be discontinued, the original database
must be re-instantiable upon request by any reader
wishing to review the work, without undue administra-
tive, operational or technical barriers, and wherever pos-
sible, future-proofed. Likewise, any Web service with its
computational or database backends should also be
similarly deposited in a re-instantiable form. A proto-
type system [10] is currently being worked on to imple-
ment as many stakeholder requests for features to be
added to the system to facilitate ease of deposition.
Deposited material with accompanying metadata will
be compliant with minimum information standards as
described below, as well as harmonized with those of
other initiatives, such as those in the MIBBI project [8]
and that of the International Biocuration Society [13],
its BioDBCore specification [14] and others.
Re-instantiability and reproducibility
To facilitate any research work that might require tech-
nical assistance for re-instantiability, we have developed
a virtual machine (VM) platform that can be used on
any current operating system to replay back an operat-
ing system image of the entire database, software appli-
cation or Web service [11]. This platform is based on
Slax, a LiveCD-based Slackware distribution of the
Linux operating system which we have configured for
bioinformatics (BioSlax). Based on our success of this
re-instantiable platform on VMs (such as VMware’sv i r -
tual machine platform) running on any current operat-
ing systems, or on full hardware virtualization of cloud
computing platforms (such as the open source Citrix
Xen® Hypervisor for virtualization of operating systems
across a wide range of CPU architectures), we envisage
the possibility of full compliance to the requirement of
re-instantiability.
As more such stable, standards-based platforms of dif-
ferent operating systems can be achieved, on which our
authors can wrap their online services in re-instantiable
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nity can progress to a level of peer-review where the
reviewer does not need to take the data and the research
procedures solely on good faith. Our reviewers in the
peer-review process can selectively or comprehensively
take author-submitted data and subject them to as
much rigour as they wish in testing the validity of
claims made by the authors. Unlike wet-laboratory
experiments, where reviewers use their best judgement
to consider whether the experimental disclosure is suffi-
cient for reproduction by any personal skilled in the art,
and where experiments require great time and expense
to be repeated during the review process, the rigour of
the review process for bioinformatics investigations can
reach a level where the author’s in silico experiments
can be selectively or completely reproduced, depending
on the computational power and resources available to
the reviewer. In this way, the veracity of the claims can
be tested and any queries be raised before the paper can
be approved for publication. Moreover, any doubtable
claims can be refuted or rebutted before publication.
Any software coding errors can be detected earlier, and
any database errors fixed before public release.
For example, suppose a piece of software is described
that runs on a particular operating system. The author
might be required to provide at least one form of the
software compliant with the re-instantiable operating
system, without requiring the end user or the reviewer
to carry out complex installation procedures and face
installation problems with dependencies on other com-
ponents of software which need to be pre-installed
before the software to be published can work well. For
future proofing, the author may be required to wrap the
software together with a compatible operating system,
fully configured to be re-instantiable on a virtual
machine that may be emulated on a wider set of compa-
tible operating systems and hardware.
Supporting grid and cloud computing infrastructure
To support such re-instantiable operating systems con-
taining datasets, databases, web-resources, pre-compiled
software applications, and version control of each depos-
ited digital object, as well as the metadata describing
what is stored, large data storage platforms have to be
procured. Uniquely labeled versions and copies must be
widely distributed to ensure minimized risk of data loss
and to avoid confusion. To support the ability of
reviewers to assess the assertions of authors and to vali-
date the results pre-publication, and for readers to
reproduce the in silico experiments described by the
authors, high performance computing infrastructure
needs to be in place where datasets and software appli-
cations are co-located in a grid infrastructure or virtua-
lized in a cloud computing environment. Moreover,
there is a trend to document the scientific process for in
silico e-science and encapsulate multiple steps of a long
workflow into concise machine readable workflow inte-
gration systems including popular efforts such as
Taverna [16] and Galaxy [17]. These workflows together
with their orchestration engines, need grid and cloud
computing infrastructure in order to be used by the
publication process which we are implementing in the
MIABi effort and the BioDB100 testbed. We are cur-
rently discussing with colleagues in the virtual organiza-
tions of OpenScienceGrid.org and EUAsiaGrid for e-
infrastructure support. The issues faced in such a test
implementation will be documented and analysed for its
feasibility for wider scale deployment.
Author disambiguation
Author names, particularly Asian author names, for var-
ious reasons, have a high degree of convergence. Higher
populations of people using a smaller set of common
family or surnames, often result in author name ambi-
guities. Despite the emergence of author identifier sys-
tems such as Researcher ID from Thomson Reuters [5]
and Scopus Author ID from Elsevier [6], Open
Researcher and Contributor ID (ORCID) [7] and many
others, universal, unique and unambiguous author iden-
tifier for author disambiguation remains elusive [18].
For our BioDB100 testbed, we propose that our
authors use a self-editable author identifier with a proto-
col to equivalence synonymous identifiers on a neutral
non-publisher-specific platform. Where an author may
end up with several author identifiers on different sys-
tems, we provide an equivalencing mechanism, making
all of them synonymous, tracing back different author
identifiers to its unique owner. Any duplicate claims can
also undergo a dispute resolution mechanism to resolve
competing claims of ownership over identifiers or the
papers associated with author identifiers. Erroneous
author identifier labels, tagged to a publication, can also
lend themselves to a protocol for de-convolution. Two
or more authors with exactly the same name label on
different publications can be disambiguated. The same
author with different name labels on a publication, due
to printing errors, or due to transliteration or transla-
tional ambiguity, can also apply disambiguation using
such a system. A prototype system [3] (based on the dis-
tributed Internet domain name system) is currently
being established with user-friendly interfaces to test
usability and to develop machine-resolvable author dis-
ambiguation requests. By validating the corresponding
authors in our conference supplements and in the
BioDB100 initiative, we combine the self-assertion of
the author identifier system with an external validation
mechanism, thus providing support for the hybrid-
asserted identity model of Bilder [19].
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identifiers or DOI handles can be associated by the
author directly to the set of equivalent author identifiers
and author labels. There is now hope for a person who
has changed names, in the case of women changing
family names upon marriage, or of name order changes,
for instance a fictitious Vivian George who previously
used George Vivian or G. Vivian because this was the
country convention in India (family or father’so rv i l l a g e
name abbreviated into an initial), now decides to switch
t oV .G e o r g eb e c a u s eh ei sb a s e di nt h eU S ,w h e r el a s t
names come last. There is also a linking mechanism for
authors who have changed fields, as well as those who
are victims of errors of author identifier systems, such
as those giving the same author more than one identifier
because of the best guess attempt by an automated sys-
tem that failed to determine that two papers were pub-
lished by the same person, and because of time,
geographic distance, differences in affiliation or disparate
fields of study, they were given two different unique
author identifiers.
Minimum Information about a Bioinformatics
Investigation (MIABi)
In 2001, efforts to compare microarray experiments
eventually led to a standardization known as the Mini-
mum Information about Microarray Experiments
(MIAME) [20]. Since then, many other minimum infor-
mation standards have appeared, now coordinated by
the project on Minimum Information about a Biological
or Biomedical Investigation (MIBBI) [8]. We would like
to draw the community’s attention to the Minimum
Information about a Bioinformatics investigation
(MIABi) initiative, which specifies, through a series of
documentation modules, the minimum information that
should be provided for a bioinformatics investigation.
Developed through a joint effort by the Asia-Pacific
Bioinformatics Network (APBioNet) (http://www.apbi-
onet.org/) and the wider bioinformatics community [21],
the MIABi initiative arises from a response to the grow-
ing need for transparency, provenance and scientific
reproducibility amongst the bioinformatics and compu-
tational biology community. Currently, it is increasingly
common for computational tools to be applied to ever
larger datasets in order to generate output with little
commensurate effort to review objectively the quality of
the process undertaken, or the quality of the input data,
analytical process, or the conclusions drawn. MIABi
plays a key role in at least one of the steps taken to pre-
vent any decline in the overall value of the scientific
publications in bioinformatics and computational biol-
ogy. It also aims at “minimizing the reporting require-
ments while maximizing the information available to
those interpreting the results” of a bioinformatics
database, resource, software application or algorithm,
analysis or in silico experiment.
The guidelines (see Additional File 1) cover the Mini-
mum Information About a Bioinformatics i) algorithm,
ii) analysis, iii) database or resource, iv) software, and v)
Web server. The MIABi scope and workflow is shown
in Figures 1 and 2. This MIABi compliance will require,
firstly, for authors to be issued with unique author iden-
tifiers (http://aid.apbionet.org/) for identity disambigua-
tion and accountability purposes. Authors with multiple
identifiers issued by various publishers (e.g. Scopus
author ID, ResearcherID) as mentioned above, can now
be resolved to a unique individual through cross-refer-
encing and synonymization of these identifiers. Sec-
ondly, it will require deposition of scientific datasets
through a central portal (e.g. http://docid.apbionet.org/)
for persistence, provenance, accessibility and reproduci-
bility. All databases, datasets and codes cited in papers
published through such processes may be mandated to
be archived in this way, supported by distributed reposi-
tory nodes, such as that of the Asian Bioinformation
Center initiative and the nascent e-Science Collabora-
tion between Asia-Pacific and Europe (eSCAPE). More-
over, a database on a pre-configured operating system
(OS) such as BioSlax (http://www.bioslax.com) can also
be archived as an image and stored at such repositories.
Should the original database server be unavailable, the
database-OS image can be dynamically re-instantiated
on demand via a cloud computing virtualized platform.
Other activities in bioinformatics such as phylogenetic
analysis, which has already been initiated by the Mini-
mum Information About a Phylogenetic Analysis
(MIAPA) group [22] or for the curation of databases
[14], which is being initiatied by the International
Society for Biocuration [13], may be referenced, inte-
grated or unified, wherever appropriate. By following the
general trend in the bioscience community for the stan-
dardization of reporting, MIABi will be registered with
the MIBBI Project [8], so as to promote and coordinate
the development, management and harmonization of
Minimum Information (MI) specifications from across
the biological and biomedical sciences.
In keeping with the acceptable processes in the develop-
ment and growing adoption of MI standards, MIABi
aims to be as applicable as possible to a wide range of
computational technologies.
Currently, the full MIABi document is divided into
five sections: i) algorithm, ii) analysis, iii) database or
r e s o u r c e ,i v )s o f t w a r e ,a n dv )W e bs e r v e r( F i g u r e2 ) .
Each section is subdivided as follows: 1) scope of the MI
for the subject bioinformatics investigation; 2) purpose
and the MI for the subject bioinformatics investigation,
including reproducibility, reusability, and validation of
claims as published in scientific publications; 3)
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formatics investigation conforming to MIABi standards
and 4) content of the subject MI, including general
descriptions, input data and parameters, output data,
workflow of process, regression testing, performance
and scalability, and provenance, where applicable. For
the MIABi for databases (MIABi-DB), we are working
with the International Biocuration Society on harmoni-
zation of our schema with their BioDBcore checklists
[14, personal communication with P Gaudet, S-A San-
sone and Biocuration team members].
Standardization of terminologies
At its current incarnation, MIABi will not mandate all
dataset or database submissions to be fully compliant
with standard nomenclature, controlled vocabularies and
standard ontologies, for the practical reason that many
scientific communities may not be ready to agree to the
standardization process or competing standards or that
there are no standard terminologies in many rapidly
growing fields. Nevertheless, it is our hope that where
communities are ready, they should be able to build
their vocabularies, formulate their field-specific ontolo-
gies, and develop consistent processes for their updates
and provide the semantic platform for building consis-
tent terminologies that pertain to that field. Once this is
done, any terminology inconsistency between fields and
subfields can be addressed, and any collision of termi-
nology de-collided or disambiguated. In a decontextua-
lised state, similar or identical terms create confusion
for reasoning engines or natural language processing.
Perhaps a universal terminology deconvolution engine
might help, very much like a scaled-up version of Wiki-
pedia’s disambiguation system.
Discussion
Through our effort to implement MIABi standards and
to test it on real world databases in the BioDB100 pro-
ject, we hope that in the conceivable future, a research
publication in bioinformatics will not only consist of the
typical paper, but also as a matter of common practice,
include deposited and quality-controlled metadata about
the research process; in addition, any database, software
or datasets arising from the publication shall be accessi-
ble from a globally distributed repository in a standards-
compliant form, ready for reproducibility of the pub-
lished results and for reusability in future research (with
due consideration to the copyright owners and the
authors).
From the outcome of the key issues covered in this
standardization deployment project, we hope that suffi-
cient lessons will be learnt such that we can create a
community of researchers and stakeholders who are
open to the standardization process, and attain a set of
Figure 1 Content overview in MIABi. The sections and sub-sections of the full MIABi document are set out.
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of developing policy and procedural protocols that
derive from this endeavour will hopefully be sufficiently
robust for us to test on a standards-compliant set of
biological databases which the APBioNet plans to initi-
ate as the BioDB100 project. This set of the first 100
biological databases contributed by our Asia-Pacific
community and beyond, can then be used as a basis for
informed debate and discussion, and may eventually
serve as an exemplar towards the wider standardization
of bioinformatics activities.
Additional materail
Additional File 1: MIABi Reporting guidelines for a bioinformatics
investigation (MIABi version 1.01).
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